These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 23686119)

  • 1. Human papillomavirus tumor-infiltrating T-regulatory lymphocytes and P53 codon 72 polymorphisms correlate with clinical staging and prognosis of oropharyngeal cancer.
    Rittà M; Landolfo V; Mazibrada J; De Andrea M; Dell'Oste V; Caneparo V; Peretti A; Giordano C; Pecorari G; Garzaro M; Landolfo S
    New Microbiol; 2013 Apr; 36(2):133-44. PubMed ID: 23686119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 codon 72 polymorphisms in human papillomavirus-negative and human papillomavirus-positive squamous cell carcinomas of the oropharynx.
    Perrone F; Mariani L; Pastore E; Orsenigo M; Suardi S; Marcomini B; DaRiva L; Licitra L; Carbone A; Pierotti MA; Pilotti S
    Cancer; 2007 Jun; 109(12):2461-5. PubMed ID: 17492690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD8-alpha T-cell infiltration in human papillomavirus-related oropharyngeal carcinoma correlates with improved patient prognosis.
    Jung AC; Guihard S; Krugell S; Ledrappier S; Brochot A; Dalstein V; Job S; de Reynies A; Noël G; Wasylyk B; Clavel C; Abecassis J
    Int J Cancer; 2013 Jan; 132(2):E26-36. PubMed ID: 22890882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 Codon 72 polymorphism, loss of heterozygosity and high-risk human papillomavirus infection in a low-incidence German esophageal squamous cell carcinoma patient cohort.
    Pantelis A; Pantelis D; Ruemmele P; Hartmann A; Hofstaedter F; Buettner R; Bootz F; Stoehr R
    Oncol Rep; 2007 May; 17(5):1243-8. PubMed ID: 17390072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD56-positive lymphocyte infiltration in relation to human papillomavirus association and prognostic significance in oropharyngeal squamous cell carcinoma.
    Wagner S; Wittekindt C; Reuschenbach M; Hennig B; Thevarajah M; Würdemann N; Prigge ES; von Knebel Doeberitz M; Dreyer T; Gattenlöhner S; Klussmann JP
    Int J Cancer; 2016 May; 138(9):2263-73. PubMed ID: 26662627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human Papillomavirus 16 Physical Status and the TP53 Codon 72 Polymorphism in Japanese HPV-Positive Oropharyngeal Cancer Patients.
    Saito Y; Ando M; Fujimoto C; Omura G; Kobayashi K; Asakage T; Yamasoba T
    ORL J Otorhinolaryngol Relat Spec; 2016; 78(1):46-54. PubMed ID: 26785263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human papillomavirus infections and upper aero-digestive tract cancers: the ARCAGE study.
    Anantharaman D; Gheit T; Waterboer T; Abedi-Ardekani B; Carreira C; McKay-Chopin S; Gaborieau V; Marron M; Lagiou P; Ahrens W; Holcátová I; Merletti F; Kjaerheim K; Talamini R; Simonato L; Castellsague X; Macfarlane TV; Biggs AM; Thakker N; Znaor A; Thomson P; Canova C; Conway DI; Healy CM; Tommasino M; Pawlita M; Brennan P
    J Natl Cancer Inst; 2013 Apr; 105(8):536-45. PubMed ID: 23503618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viral RNA patterns and high viral load reliably define oropharynx carcinomas with active HPV16 involvement.
    Holzinger D; Schmitt M; Dyckhoff G; Benner A; Pawlita M; Bosch FX
    Cancer Res; 2012 Oct; 72(19):4993-5003. PubMed ID: 22991302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic and local human papillomavirus 16-specific T-cell immunity in patients with head and neck cancer.
    Heusinkveld M; Goedemans R; Briet RJ; Gelderblom H; Nortier JW; Gorter A; Smit VT; Langeveld AP; Jansen JC; van der Burg SH
    Int J Cancer; 2012 Jul; 131(2):E74-85. PubMed ID: 22020783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defining molecular phenotypes of human papillomavirus-associated oropharyngeal squamous cell carcinoma: validation of three-class hypothesis.
    Weinberger PM; Yu Z; Kountourakis P; Sasaki C; Haffty BG; Kowalski D; Merkley MA; Rimm DL; Camp RL; Psyrri A
    Otolaryngol Head Neck Surg; 2009 Sep; 141(3):382-9. PubMed ID: 19716018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human papillomavirus type 16 oropharyngeal cancers in lymph nodes as a marker of metastases.
    Mirghani H; Moreau F; Lefèvre M; Tam C; Périé S; Soussan P; St Guily JL
    Arch Otolaryngol Head Neck Surg; 2011 Sep; 137(9):910-4. PubMed ID: 21930979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oropharyngeal squamous cell carcinomas differentially express granzyme inhibitors.
    van Kempen PM; Noorlag R; Swartz JE; Bovenschen N; Braunius WW; Vermeulen JF; Van Cann EM; Grolman W; Willems SM
    Cancer Immunol Immunother; 2016 May; 65(5):575-85. PubMed ID: 26993499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 codon 72 polymorphism associated with risk of human papillomavirus-associated squamous cell carcinoma of the oropharynx in never-smokers.
    Ji X; Neumann AS; Sturgis EM; Adler-Storthz K; Dahlstrom KR; Schiller JT; Wei Q; Li G
    Carcinogenesis; 2008 Apr; 29(4):875-9. PubMed ID: 18258602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of HPV16 African variants and quantitative analysis of viral DNA methylation in oropharyngeal squamous cell carcinomas.
    Barbieri D; Nebiaj A; Strammiello R; Agosti R; Sciascia S; Gallinella G; Landini MP; Caliceti U; Venturoli S
    J Clin Virol; 2014 Jul; 60(3):243-9. PubMed ID: 24845262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the codon 72 polymorphism of TP53 and human papillomavirus infection in Iranian patients with prostate cancer.
    Salehi Z; Hadavi M
    J Med Virol; 2012 Sep; 84(9):1423-7. PubMed ID: 22825821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus in oropharyngeal squamous cell carcinoma: assessing virus presence in normal tissue and activity in cervical metastasis.
    Laborde RR; Janus JR; Olsen SM; Wang VW; Garcia JJ; Graham RP; Moore EJ; Olsen KD; Kasperbauer JL; Price DL; Berres M; Halling G; Smith DI
    Laryngoscope; 2012 Dec; 122(12):2707-11. PubMed ID: 22961429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No evidence for active human papillomavirus (HPV) in fields surrounding HPV-positive oropharyngeal tumors.
    Rietbergen MM; Braakhuis BJ; Moukhtari N; Bloemena E; Brink A; Sie D; Ylstra B; Baatenburg de Jong RJ; Snijders PJ; Brakenhoff RH; Leemans CR
    J Oral Pathol Med; 2014 Feb; 43(2):137-42. PubMed ID: 24118314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-infiltrating B cells affect the progression of oropharyngeal squamous cell carcinoma via cell-to-cell interactions with CD8
    Hladíková K; Koucký V; Bouček J; Laco J; Grega M; Hodek M; Zábrodský M; Vošmik M; Rozkošová K; Vošmiková H; Čelakovský P; Chrobok V; Ryška A; Špíšek R; Fialová A
    J Immunother Cancer; 2019 Oct; 7(1):261. PubMed ID: 31623665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and characteristics of HPV infection in oropharyngeal cancer.
    De Stefani A; Boffano P; Averono G; Ramella A; Pia F; Bongioannini G
    J Craniofac Surg; 2013 Jan; 24(1):e40-3. PubMed ID: 23348332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inverse relationship between human papillomavirus-16 infection and disruptive p53 gene mutations in squamous cell carcinoma of the head and neck.
    Westra WH; Taube JM; Poeta ML; Begum S; Sidransky D; Koch WM
    Clin Cancer Res; 2008 Jan; 14(2):366-9. PubMed ID: 18223210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.